A carregar...
Mesenchymal Stem Cells as a biological drug for heart disease: Where are we with cardiac cell-based therapy?
Cell-based treatment represents a new generation in the evolution of biological therapeutics. A prototypic cell-based therapy, the mesenchymal stem cell (MSC), has successfully entered phase III pivotal trials for heart failure, signifying adequate enabling safety and efficacy data from phase I and...
Na minha lista:
| Publicado no: | Circ Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4571454/ https://ncbi.nlm.nih.gov/pubmed/26185208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.117.306306 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|